| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |